Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

WALGREENS BOOTS ALLIANCE, INC.

(WBA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/20/2021 09/21/2021 09/22/2021 09/23/2021 09/24/2021 Date
48.4(c) 48.02(c) 48.01(c) 48.46(c) 48.38 Last
5 325 475 4 614 451 3 896 394 2 947 164 1 562 008 Volume
-2.46% -0.79% -0.02% +0.94% -0.17% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 132 B - -
Net income 2021 2 602 M - -
Net Debt 2021 9 557 M - -
P/E ratio 2021 16,4x
Yield 2021 3,90%
Sales 2022 136 B - -
Net income 2022 3 734 M - -
Net Debt 2022 7 994 M - -
P/E ratio 2022 11,3x
Yield 2022 4,04%
Capitalization 41 917 M 41 917 M -
EV / Sales 2021 0,39x
EV / Sales 2022 0,37x
Nbr of Employees 277 000
Free-Float 61,0%
More Financials
Company
Walgreens Boots Alliance, Inc. is a holding company. The Company operates through three segments: Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Retail Pharmacy USA segment consists of the Walgreen Co. (Walgreens) business, which includes the operation of retail drugstores, care clinics and providing specialty pharmacy services. The Retail Pharmacy International segment consists... 
Sector
Drug Retailers
Calendar
10/14 | 07:00amEarnings Release
More about the company
Ratings of Walgreens Boots Alliance, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about WALGREENS BOOTS ALLIANCE, INC.
10:15aWALGREENS BOOTS ALLIANCE : Stores Start Offering Pfizer's COVID-19 Booster Doses
MT
09:52aWALGREENS : Announces Pfizer COVID-19 Vaccine Booster Shots Now Available Nationwide for E..
BU
08:16aWalgreens Rolls Out More Pfizer Booster Shots
DJ
09/23WALGREENS BOOTS ALLIANCE : U.S. CDC backs COVID-19 boosters for high-risk adults, workers,..
RE
09/22Oak Street Real Estate Capital, LLC acquired 1.68-acre property at 3600 Winter Garden V..
CI
09/21WALGREENS BOOTS ALLIANCE : to Raise Stake in Shields Health Solutions Via $970 Million Inv..
MT
09/21Walgreens Boots Subsidiary Makes $970 Million Investment in Shields Health
DJ
09/21WALGREENS BOOTS ALLIANCE : Agreement accelerates Shields' health system-based platform to ..
PU
09/21WALGREENS BOOTS ALLIANCE : makes $970 million investment in specialty pharmacy company Shi..
RE
09/21WALGREENS BOOTS ALLIANCE : Makes Majority Investment in Shields Health Solutions, Expandin..
BU
09/21WALGREENS BOOTS ALLIANCE, INC. : Entry into a Material Definitive Agreement, Regulation FD..
AQ
09/20WALGREENS BOOTS ALLIANCE : Announces New Bonuses and Rewards to Further Support and Recogn..
AQ
09/20WALGREENS BOOTS ALLIANCE : CVS Health to hire 25,000 ahead of flu season, COVID-19 booster..
RE
09/17WALGREENS BOOTS ALLIANCE : heaps bonuses, rewards for pharmacists amid labor shortage
RE
09/17WALGREENS BOOTS ALLIANCE : Offers Employees $200 in Store Credits for Full COVID-19 Vaccin..
MT
More news
News in other languages on WALGREENS BOOTS ALLIANCE, INC.
10:15aLes magasins Walgreens commencent à proposer des doses de rappel de COVID-19 de Pfizer
09/21Walgreens Boots Alliance augmente sa participation dans Shields Health Solutions par un..
09/17Walgreens propose aux employés 200 $ de crédits en magasin pour une vaccination complèt..
09/16USA : Biden ottiene input da dirigenti aziendali su obbligo vaccinale
09/15USA : Biden incontro con dirigenti Walgreens, Microsoft su obbligo vaccinale
More news
Analyst Recommendations on WALGREENS BOOTS ALLIANCE, INC.
More recommendations
Chart WALGREENS BOOTS ALLIANCE, INC.
Duration : Period :
Walgreens Boots Alliance, Inc. Technical Analysis Chart | WBA | US9314271084 | MarketScreener
Technical analysis trends WALGREENS BOOTS ALLIANCE, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 22
Last Close Price 48,46 $
Average target price 53,45 $
Spread / Average Target 10,3%
EPS Revisions
Managers and Directors
Rosalind Gates Brewer Chief Executive Officer & Director
James Kehoe Global Chief Financial Officer & Executive VP
Stefano Pessina Executive Chairman
Francesco Tinto Global Chief Information Officer & Senior VP
Ornella Barra Chief Operating Officer
Sector and Competitors